Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 22 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
DRUGMAND & MEERT from Sint-Jans-Molenbeek, company number BE0401882084, closed financial year 2025 with a result of € -37,313 after tax. For that financial year DRUGMAND & MEERT recorded revenue of € 4.3 million and equity of € 1.1 million. Compared with financial year 2024, the result moved from € 139,445 to € -37,313. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 30, 2026.
€ 1.1 million
▼ 3% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -37,313
▼ still € 139,445 profit in 2024
Profit after tax over the fiscal year.
€ 37,349
▲ € 32,357 vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -690,329.
People and assets in 2025
7.2
▲ 0.2 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 773,285
▲ 19% vs 2024
€ 107,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
€ 1.5 million
▲ 7% vs 2024
€ 11,761 is repaid this year. At this pace the long-term loan is gone in ≈ 79 years.
€ 332,400
▼ 3% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 120,269
▼ 19% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | - | - | - | € 4,281,129 | |
| Gross margin | € 686,205 | € 971,356 | € 1,042,344 | € 820,981 | ▼ 21% |
| Profit after taxes | € 15,517 | € 106,982 | € 139,445 | € -37,313 | ▼ € 176,759 |
| Equity | € 851,201 | € 958,182 | € 1,097,628 | € 1,059,410 | ▼ 3% |
| Total debts | € 3,778,877 | € 3,238,695 | € 2,817,287 | € 3,120,876 | ▲ 11% |
| Cash | € 10,028 | € 9,704 | € 4,992 | € 37,349 | ▲ € 32,357 |
| Retained profit | € -898,539 | € -791,557 | € -652,112 | € -690,329 | ▼ € 38,217 |
| Bank debt | € 1,822,213 | € 1,495,594 | € 1,378,994 | € 1,472,030 | ▲ 7% |
| Balance sheet total | € 4,630,078 | € 4,196,877 | € 3,914,915 | € 4,180,286 | ▲ 7% |
| Employees (FTE) | 6.4 | 6.7 | 7 | 7.2 | ▲ 0.2 |
Key figures of DRUGMAND & MEERT, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to DRUGMAND & MEERT?
What happened at DRUGMAND & MEERT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 37,313 (▼ € 176,759 vs 2024). Source: NBB ↗
- Start of the company according to the CBE. KBO
- New establishment in Sint-Jans-Molenbeek. KBO
- New establishment in Vilvoorde. KBO
In short
From € 15,517 profit in 2022 to € 37,313 loss in 2025.
Paid € 129,843 in corporate taxes since 2022.
Best year ever: 2024, with € 139,445 profit.
On average € 114,000 of value added per employee in 2025.
A new publication or filing at DRUGMAND & MEERT? We notify you, reason included.
Follow DRUGMAND & MEERTDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of GECOM comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
DRUGMAND & MEERTBehind DRUGMAND & MEERT is Christophe DRUGMAND. The shares are held by GECOM (2.5%). It owns 100% of Equipement Machines et appareils spéciaux and 98.4% of GECOM itself.
Directors
According to the 2025 annual accounts
Christophe DRUGMAND
Managing director
Also active at: GECOM, Équipement, Machines et Appareils Spéciaux
Shareholders
2.5%
Participations
Establishments
Establishment units
Physical locations of this company
Vier-Windenstraat 70A
1080 Sint-Jans-Molenbeek
de Bavaylei 110
1800 Vilvoorde
Active since 1 December 1947
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0401.882.084
- VAT number
- BE 0401.882.084
- Registered office
- Vier-Windenstraat 70A, 1080 Sint-Jans-Molenbeek
- Names & denominations
- DRUGMAND & MEERT · DRUGMAND
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 9 January 1948
- Peppol
- Active · Active since 13 Jan 2026
- Contact
- [email protected]
- Activities · NACE
Vervaardiging van andere producten van kunststof
Vervaardiging van overige producten van kunststof
Vervaardiging van elektromotoren en van elektrische generatoren en transformatoren